BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11167802)

  • 1. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features.
    Saunthararajah Y; Molldrem JL; Rivera M; Williams A; Stetler-Stevenson M; Sorbara L; Young NS; Barrett JA
    Br J Haematol; 2001 Jan; 112(1):195-200. PubMed ID: 11167802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance.
    Zhang X; Sokol L; Bennett JM; Moscinski LC; List A; Zhang L
    Leuk Res; 2016 Apr; 43():18-23. PubMed ID: 26927701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases.
    Huh YO; Medeiros LJ; Ravandi F; Konoplev S; Jorgensen JL; Miranda RN
    Am J Clin Pathol; 2009 Mar; 131(3):347-56. PubMed ID: 19228641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
    Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Auto- and alloreactivity of T lymphocytes in myelodysplastic syndrome].
    Cukrová V; Neuwirtová R; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
    Cas Lek Cesk; 2006; 145(8):647-52; discussion 653. PubMed ID: 16995421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed myelodysplastic and myeloproliferative syndromes.
    Neuwirtová R; Mociková K; Musilová J; Jelínek J; Havlícek F; Michalová K; Adamkov M
    Leuk Res; 1996 Sep; 20(9):717-26. PubMed ID: 8947580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
    Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
    Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome.
    Kardos G; Veerman AJ; de Waal FC; van Oudheusden LJ; Slater R
    Med Pediatr Oncol; 1996 Jan; 26(1):54-6. PubMed ID: 7494512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
    Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia.
    Benites BD; Traina F; Duarte Ada S; Lorand-Metze IG; Costa FF; Saad ST
    Eur J Haematol; 2010 Jun; 84(6):525-30. PubMed ID: 20345447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood chromosome aberrations in MDS.
    White AD; Jacobs A
    Cancer Genet Cytogenet; 1992 Apr; 59(2):167-72. PubMed ID: 1581882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells.
    Sood R; Stewart CC; Aplan PD; Murai H; Ward P; Barcos M; Baer MR
    Blood; 1998 May; 91(9):3372-8. PubMed ID: 9558395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell large granular lymphocyte leukemia and related disorders.
    Rose MG; Berliner N
    Oncologist; 2004; 9(3):247-58. PubMed ID: 15169980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome abnormalities in the myelodysplastic syndromes.
    Heim S; Mitelman F
    Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific minor chromosome deletions in myelodysplastic syndromes: clinical and morphologic correlations.
    Kerndrup G; Pedersen B; Bendix-Hansen K
    Cancer Genet Cytogenet; 1987 Jun; 26(2):227-34. PubMed ID: 3567876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia.
    Goel R; Kumar R; Bakhshi S
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):725-7. PubMed ID: 17921857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
    Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
    Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.